ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 2, 2011, Pages 545-554

  Cervantes Gomez, Fabiola ^a,b   Nimmanapalli, Ramadevi ^c   Gandhi, Varsha ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TUSKEGEE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA; PROTEIN KINASE B; RAF PROTEIN; RETASPIMYCIN; STAT3 PROTEIN;

ARTICLE; BIOENERGY; CELL DEATH; CELL METABOLISM; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME STABILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RNA SYNTHESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BENZOQUINONES; CELL DEATH; CELL LINE, TUMOR; DEOXYADENOSINES; DRUG SYNERGISM; HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; MULTIPLE MYELOMA; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; RAF KINASES; RNA; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 80054791413     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.184903     Document Type: Article

References (40)

1. Bagatell R, Paine-Murrieta GD, Taylor CW, Pulcini EJ, Akinaga S, Benjamin IJ, and Whitesell L (2000) Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. Clin Cancer Res 6:3312-3318. (Pubitemid 30637762)
2. Balakrishnan K, Stellrecht CM, Genini D, Ayres M, Wierda WG, Keating MJ, Leoni LM, and Gandhi V (2005) Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP. Blood 105:4455-4462. (Pubitemid 40720794)
3. Baler R, Dahl G, and Voellmy R (1993) Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Mol Cell Biol 13:2486-2496. (Pubitemid 23097727)
4. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, and Green DR (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2:469-475.
5. Biamonte MA, Van de Water R, Arndt JW, Scannevin RH, Perret D, and Lee WC (2010) Heat shock protein 90: inhibitors in clinical trials. J Med Chem 53:3-17.
6. Cervantes-Gomez F, Nimmanapalli R, and Gandhi V (2009) Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17- demethoxygeldanamycin and actinomycin D. Cancer Res 69:3947-3954.
7. Chatterjee M, Jain S, Stühmer T, Andrulis M, Ungethüm U, Kuban RJ, Lorentz H, Bommert K, Topp M, Krämer D, et al. (2007) STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival. Blood 109:720-728. (Pubitemid 46105974)
8. Chen LS, Du-Cuny L, Vethantham V, Hawke DH, Manley JL, Zhang S, and Gandhi V (2010) Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues. Biochem Pharmacol 79:669-677.
9. Chen LS, Nowak BJ, Ayres ML, Krett NL, Rosen ST, Zhang S, and Gandhi V (2009) Inhibition of ATP synthase by chlorinated adenosine analogue. Biochem Pharmacol 78:583-591.
10. Chen LS and Sheppard TL (2004) Chain termination and inhibition of Saccharomyces cerevisiae poly(A) polymerase by C-8-modified ATP analogs. J Biol Chem 279:40405-40411. (Pubitemid 39287629)
11. Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, and Blagosklonny MV (2006) Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ 13:1434-1441. (Pubitemid 44210347)
12. Dey A, Wong ET, Cheok CF, Tergaonkar V, and Lane DP (2008) R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapy. Cell Death Differ 15:263-273.
13. Gandhi V, Ayres M, Halgren RG, Krett NL, Newman RA, and Rosen ST (2001) 8-Chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res 61:5474-5479. (Pubitemid 32694929)
14. Ghias K, Ma C, Gandhi V, Platanias LC, Krett NL, and Rosen ST (2005) 8-Aminoadenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma. Mol Cancer Ther 4:569-577. (Pubitemid 40601838)
15. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, and Hay N (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt- (PKB) signaling pathway. Genes Dev 12:502-513. (Pubitemid 28101013)
16. Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R, and Sonenberg N (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15:2852-2864. (Pubitemid 33042055)
17. Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, and Espinosa JM (2006) Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev 20:601-612. (Pubitemid 43345325)
18. Guo Y, Guettouche T, Fenna M, Boellmann F, Pratt WB, Toft DO, Smith DF, and Voellmy R (2001) Evidence for a mechanism of repression of heat shock factor 1 transcriptional activity by a multichaperone complex. J Biol Chem 276:45791-45799.
19. Hartl FU and Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-1858. (Pubitemid 34214115)
20. Hunt C and Morimoto RI (1985) Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci USA 82:6455-6459. (Pubitemid 16230532)
21. Lis J and Wu C (1993) Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell 74:1-4. (Pubitemid 23219872)
22. Ljungman M, Zhang F, Chen F, Rainbow AJ, and McKay BC (1999) Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18:583-592. (Pubitemid 29080315)
23. Martins AS, Ordoñez JL, García-Sánchez A, Herrero D, Sevillano V, Osuna D, Mackintosh C, Caballero G, Otero AP, Poremba C, et al. (2008) A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study. Cancer Res 68:6260-6270.
24. Miller RT, Glover SE, Stewart WS, Corton JC, Popp JA, and Cattley RC (1996) Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643. Carcinogenesis 17:1337-1341.
25. Neckers L and Neckers K (2002) Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents. Expert Opin Emerg Drugs 7:277-288. (Pubitemid 35291458)
26. Onuoha SC, Coulstock ET, Grossmann JG, and Jackson SE (2008) Structural studies on the co-chaperone Hop and its complexes with Hsp90. J Mol Biol 379:732-744.
27. Pandey P, Farber R, Nakazawa A, Kumar S, Bharti A, Nalin C, Weichselbaum R, Kufe D, and Kharbanda S (2000) Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19:1975-1981. (Pubitemid 30229410)
28. Peng X, Guo X, Borkan SC, Bharti A, Kuramochi Y, Calderwood S, and Sawyer DB (2005) Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes. J Biol Chem 280:13148-13152.
29. Pratt WB and Toft DO (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228:111-133. (Pubitemid 36187918)
30. Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, and Pearl LH (1997) Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90:65-75. (Pubitemid 28009419)
31. Richardson PG, Mitsiades CS, Laubach JP, Lonial S, Chanan-Khan AA, and Anderson KC (2011) Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers. Br J Haematol 152:367-379.
32. Schnur RC, Corman ML, Gallaschun RJ, Cooper BA, Dee MF, Doty JL, Muzzi ML, DiOrio CI, Barbacci EG, and Miller PE (1995) erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. J Med Chem 38:3813-3820.
33. Sharp S and Workman P (2006) Inhibitors of the HSP90 molecular chaperone: current status. Adv Cancer Res 95:323-348. (Pubitemid 44088424)
34. Smith DF, Sullivan WP, Marion TN, Zaitsu K, Madden B, McCormick DJ, and Toft DO (1993) Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol Cell Biol 13:869-876. (Pubitemid 23040252)
35. Stellrecht CM, Ayres M, Arya R, and Gandhi V (2010) A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels. Breast Cancer Res Treat 121:355-364.
36. Stellrecht CM, Phillip CJ, Cervantes-Gomez F, and Gandhi V (2007) Multiple myeloma cell killing by depletion of the MET receptor tyrosine kinase. Cancer Res 67:9913-9920. (Pubitemid 47621240)
37. Stellrecht CM, Rodriguez CO Jr, Ayres M, and Gandhi V (2003) RNA-directed actions of 8-chloro-adenosine in multiple myeloma cells. Cancer Res 63:7968-7974. (Pubitemid 37466734)
38. Whitesell L and Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761-772. (Pubitemid 41400776)
39. Winegarden NA, Wong KS, Sopta M, and Westwood JT (1996) Sodium salicylate decreases intracellular ATP, induces both heat shock factor binding and chromosomal puffing, but does not induce hsp 70 gene transcription in Drosophila. J Biol Chem 271:26971-26980. (Pubitemid 26359112)
40. Wu C (1995) Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 11:441-469.